Do Prices on Ticketmaster Suddenly Seem Much Higher? You're Not Alone.
For years now, the Ticketmaster experience has been defined by hitting the checkout button and seeing the price of your ticket purchase jump, sometimes nearly double, thanks to so-called 'service fees.' Finally, that is going to change. No, Ticketmaster isn't getting rid of the service charges. But it will now display the full cost of the purchase, fees included, from the very start of your transaction.
In a blog post, Ticketmaster announced its so-called 'all-in pricing,' which starts Monday, May 12. 'With All In Prices, you'll be able to find tickets within your budget right away, with no surprises at checkout. That's because you'll see the cost of your ticket—including fees, before taxes—from the moment you start shopping for any Ticketmaster event in the US,' the company said.
Why is Ticketmaster introducing its new pricing that transparently reflects the actual cost of tickets? To hear Ticketmaster's version of events, this is something it has wanted all along. 'We're all in on putting fans first. We've long advocated for all-in pricing laws worldwide, and support a consistent ticket-buying experience for fans,' the company claimed in a blog post.
There is something quite funny about Ticketmaster turning this into some sort of new feature and positioning itself as being pro-consumer, as if someone forced it to operate with hidden fees that only appear at checkout all this time. Ticketing fees have been an issue for a long time, with Ticketmaster being one of the biggest culprits. A 2018 Government Accountability Office report found that service fees hit ticket buyers with costs that add, on average, 27% to 31% of the advertised ticket price to their final purchase.
When the Biden administration started pursuing its crackdown on junk fees, Ticketmaster promised to go along with the changes—but spent more of its efforts skirting and fighting them. Per the Washington Post, the ticketing giant started showing the full purchase price on tickets only for shows at Live Nation venues, a company Ticketmaster merged with back in 2010. The company also ramped up its lobbying spending as soon as the junk fee rules started to be discussed. That doesn't exactly seem like the kind of thing a company that has always wanted price transparency would do.
Instead, the explanation for Ticketmaster's 'All In Pricing,' the groundbreaking concept of showing what things cost, is much simpler. The Federal Trade Commission's 'Rule on Unfair or Deceptive Fees,' which requires businesses to 'clearly and conspicuously' display the total price with fees included from the jump, went into effect on May 12. Weird how that needed to become the law of the land for Ticketmaster to actually do the thing it claims it has long supported.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Vancouver company celebrating reusable food container success
started with just five stores but is now in institutions across Canada and the U.S. As Chad Pawson explains, local waste management officials say it's the type of private-sector ingenuity needed to address the region's garbage problem.
Yahoo
23 minutes ago
- Yahoo
Why Mondelez's Dividend Stands Strong in Uncertain Markets
Mondelez International, Inc. (NASDAQ:MDLZ) is one of the best dividend stocks for a bear market. Mondelez International, Inc. (NASDAQ:MDLZ) ranks among the top global snack makers and belongs to the consumer staples sector. During economic downturns, consumers typically continue buying food at consistent levels, and even tend to favor discounted options more, making large food companies like Mondelez appealing, especially when spending declines in more discretionary areas. A colourful array of products like candies, chocolates and gums on a supermarket shelf. Another reason investors are drawn to Mondelez International, Inc. (NASDAQ:MDLZ) is its strong dividend and reliable cash flow. In the latest quarter, the company generated $1.1 billion in operating cash flow and $0.8 billion in free cash flow, while returning $2.1 billion to shareholders through dividends and buybacks. Mondelez International, Inc. (NASDAQ:MDLZ) has also garnered attention on the dividend front. The company has been rewarding shareholders with growing dividends for the past 11 consecutive years. It offers a quarterly dividend of $0.47 per share and has a dividend yield of 2.83% The company has expressed confidence in its future earnings potential, which may support the strength and stability of its dividend payments. It has reaffirmed its outlook for the year, expecting organic net revenue to grow by around 5%. However, adjusted earnings per share are projected to decline by roughly 10% on a constant currency basis, mainly due to an unusual surge in cocoa prices. Despite this, the company anticipates generating over $3 billion in free cash flow for 2025. Since recessions often go hand in hand with falling stock markets, investors with shorter time horizons may find value in holding companies that offer steady or growing dividend yields. While we acknowledge the potential of MDLZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
23 minutes ago
- Yahoo
This Under-the-Radar Healthcare Stock Could Be a Solid Income Play
CVS Health Corporation (NYSE:CVS) is one of the best dividend stocks for a bear market. Even during economic downturns, people continue to rely on medications, essential consumer products, and affordable local healthcare. CVS Health Corporation (NYSE:CVS) serves as a convenient healthcare and retail destination within communities. A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products. The company's overall business remains solid, thanks to its diversified operations and multiple sources of revenue. In recent years, it has expanded its presence in primary care and launched a subsidiary called Cordavis to focus on developing and marketing biosimilar drugs. Its broad reach across communities and wide range of services are key advantages. Lately, higher Medicare usage and increased post-pandemic healthcare costs have impacted the company's revenue and earnings growth. However, CVS Health Corporation (NYSE:CVS) remains profitable and maintains a solid cash position. In the most recent quarter, it reported $4.6 billion in operating cash flow. Looking ahead to 2025, the company has raised its full-year operating cash flow forecast from around $6.5 billion to approximately $7.0 billion. In addition, CVS Health Corporation (NYSE:CVS) appears to have significant room to grow its dividend. With a cash payout ratio of just 30%, even doubling that figure would still leave it within a sustainable range. Due to this strong cash generation, CVS Health Corporation (NYSE:CVS) has maintained its payouts since 1997. Currently, it offers a quarterly dividend of $0.665 per share and has a dividend yield of 3.96%, as of June 17. While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.
